Article Details

Wave to Discontinue Lead Huntington's Programs After Disappointing Clinical Data

Retrieved on: 2021-03-30 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Wave to Discontinue Lead Huntington's Programs After Disappointing Clinical Data. View article details on hiswai:

Excerpt

Unlike Roche's tominersen, which targets all HTT alleles to reduce both mutant and health proteins, Wave's candidates each target a different single ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up